Nanoparticle-delivered RNA reduces neuroinflammation in lab tests

Some Covid-19 vaccines safely and effectively used lipid nanoparticles (LNPs) to deliver messenger RNA to cells. A new MIT study shows that different nanoparticles could be used for a potential Alzheimer’s disease (AD) therapy. In tests in multiple m

Related Keywords

Switzerland ,Swiss ,Eduardo Eurnekian ,William Ralvenius ,Lestera Gimpelson ,Li Huei Tsai ,Robert Langer ,Carroll Miller ,Rjay Penney ,Julia Maeve Bonner ,Margaret Huston ,Jason Andresen ,Owen Fenton ,Swiss National Science Foundation ,Cognitive Sciences ,Tsai Lab ,David Koch Institute Professor ,Koch Institute For Integrative Cancer Research ,Picower Institute For ,Koch Institute ,Langer Lab ,Brain Initiative ,Department Of Brain ,Alzheimer Association ,Advanced Materials ,Picower Institute ,Aging Brain Initiative ,North Carolina ,Eshelman School ,Chemical Engineering ,Biological Engineering ,Integrative Cancer ,Julia Maeve ,Renee Belfer Family ,